A4GALT: A Promising Drug Target / Biomarker (G53947)

Target Name: A4GALT

NCBI ID: G53947

A4GALT

A4GALT: A Promising Drug Target / Biomarker

A4GALT is a protein that is expressed in the endoplasmic reticulum (ER) and has been shown to play a role in various cellular processes, including cell signaling, protein folding, and intracellular trafficking. It is a member of the A protein family, which includes several similar proteins that have been shown to be involved in a variety of cellular processes. One of the most interesting features of A4GALT is its unique structure, which allows it to interact with other proteins in a highly specific and efficient manner. In this article, we will explore the biology of A4GALT and its potential as a drug target or biomarker.

Structure and Function

The A4GALT protein is a 21-kDa protein that is expressed in the ER and can interact with several different proteins. It has a unique structure that allows it to interact with other proteins in a highly specific and efficient manner. A4GALT has a molecular weight of 43.9 kDa and a calculated pI of 9.9. It has a single transmembrane domain and a cytoplasmic tail that is involved in its stability and interactions with other proteins.

One of the most interesting features of A4GALT is its unique structure, which allows it to interact with other proteins in a highly specific and efficient manner. A4GALT has a molecular weight of 43.9 kDa and a calculated pI of 9.9. It has a single transmembrane domain and a cytoplasmic tail that is involved in its stability and interactions with other proteins.

The A4GALT protein is involved in several cellular processes, including cell signaling, protein folding, and intracellular trafficking. One of the most well-studied functions of A4GALT is its role in intracellular signaling. A4GALT has been shown to play a role in the regulation of several intracellular signaling pathways, including the TGF-β pathway and the PI3K/Akt signaling pathway.

In addition to its role in intracellular signaling, A4GALT has also been shown to be involved in protein folding. A4GALT has been shown to play a role in the regulation of protein folding and stability, which is important for the function of many different proteins.

A4GALT has also been shown to be involved in intracellular trafficking. A4GALT has been shown to play a role in the transport of several different proteins to and from the ER, including the protein known as heat shock protein (Hsp70). This suggests that A4GALT may be involved in the regulation of intracellular trafficking and may be a potential drug target.

Drug Target Potential

The unique structure of A4GALT and its involvement in several cellular processes make it an attractive target for drug development. There is evidence to suggest that A4GALT may be involved in a variety of signaling pathways, including the TGF-β pathway and the PI3K/Akt signaling pathway. This suggests that A4GALT may be a potential drug target for diseases that are characterized by these signaling pathways.

In addition to its potential role in intracellular signaling and protein folding, A4GALT has also been shown to be involved in the regulation of intracellular trafficking. This suggests that A4GALT may be a potential drug target for diseases that are characterized by disruptions in intracellular trafficking.

Biomarker Potential

The unique structure of A4GALT and its involvement in several cellular processes make it an attractive target for biomarker development. A4GALT has been shown to be involved in the regulation of several intracellular signaling pathways, including the TGF-β pathway and the PI3K/Akt signaling pathway. This suggests that A4GALT may be a potential biomarker for diseases characterized by these signaling pathways.

In addition to its potential role in intracellular signaling, A4GALT has also been shown to be involved in protein folding. This suggests that A4GALT may be a potential biomarker for diseases characterized by disruptions in protein folding and stability.

Conclusion

In conclusion, A4GALT is a protein that is expressed in the ER and has been shown to play a role in various cellular processes, including cell signaling, protein folding, and intracellular trafficking. Its unique structure and involvement in several cellular processes make it an attractive target for drug development and biomarker development. Further research is needed to fully understand the role of A4GALT in cellular processes and its potential as a drug target or biomarker.

Protein Name: Alpha 1,4-galactosyltransferase (P Blood Group)

Functions: Catalyzes the transfer of galactose from UDP-alpha-D-galactose to lactosylceramide/beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(d18:1(4E)) to produce globotriaosylceramide/globoside Gb3Cer (d18:1(4E)) (PubMed:10748143). Also able to transfer galactose to galactosylceramide/beta-D-Gal-(1<->1')-Cer (PubMed:10748143). Globoside Gb3Cer is a glycosphingolipid of the globo serie, one of the major types of neutral root structures of glycosphingolipids, that constitute a significant portion of mammalian cell membranes (Probable). Globotriaosylceramide/globoside Gb3Cer in blood and tissue cell membranes is the antigen Pk of blood histogroup P (PubMed:10747952)

The "A4GALT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about A4GALT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets